Have a
regulatory affairs
challenge?
Blog posts
Pharma and Biotech
Understanding the Regulatory Environment for Decentralized Clinical Trials
The global decentralized clinical trials (DCTs) market is expected to grow from US$8.8 billion in...
Read more
Pharma and Biotech
Regulation of CBD: How the Molecule is Governed Around the Globe
While regulations governing the sale of products containing hemp and cannabis-derived compounds vary greatly by...
Read more
Pharma and Biotech
Update: Mutual Recognition Agreement between the U.S. and EU
As of July 11, 2019, the transitionary period is over, and enforcement of the Mutual Recognition...
Read more